Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phospholipid monolayers and systemic lupus erythematosus.

P B Simpson, R C Oppenheim

    The New Zealand Medical Journal
    |July 13, 1977
    PubMed
    Summary

    This study proposes procainamide causes systemic lupus erythematosus by inducing phospholipid loss from cell membranes. This leads to cell damage and the production of antinuclear antibodies, a key marker in lupus.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The JAK3 inhibitor WHI-P154 prevents PDGF-evoked process outgrowth in human neural precursor cells.

    Journal of neurochemistry·2006
    Same author

    Salicylidene salicylhydrazide, a selective inhibitor of beta 1-containing GABAA receptors.

    British journal of pharmacology·2004
    Same author

    High throughput fluorescence assays for the measurement of mitochondrial activity in intact human neuroblastoma cells.

    Journal of biomolecular screening·2002
    Same author

    Retinoic acid evoked-differentiation of neuroblastoma cells predominates over growth factor stimulation: an automated image capture and quantitation approach to neuritogenesis.

    Analytical biochemistry·2002
    Same author

    The local control of cytosolic Ca2+ as a propagator of CNS communication--integration of mitochondrial transport mechanisms and cellular responses.

    Journal of bioenergetics and biomembranes·2002
    Same author

    alpha4beta3delta GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential.

    The Journal of biological chemistry·2001

    Area of Science:

    • Immunology
    • Molecular Biology
    • Pharmacology

    Background:

    • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with complex etiology.
    • The role of specific drug interactions in SLE pathogenesis remains an area of active investigation.
    • Phospholipids are crucial components of cell membranes, and their dysregulation can impact cellular integrity.

    Purpose of the Study:

    • To investigate the molecular mechanisms by which procainamide may contribute to the development of systemic lupus erythematosus.
    • To explore the interaction between procainamide and cell membrane phospholipids.
    • To hypothesize a causal link between drug-induced phospholipid alterations and SLE.

    Main Methods:

    • Studied the molecular interactions between the drug procainamide and phospholipid monolayers.
    • Utilized biophysical techniques to analyze drug-membrane interactions at a molecular level.

    Main Results:

    • Procainamide was observed to interact with phospholipid monolayers, suggesting a potential for membrane disruption.
    • The study proposes that procainamide induces a loss of phospholipids from the cell membrane.

    Conclusions:

    • Chronic phospholipid loss induced by procainamide may lead to cell lysis.
    • This cellular damage could trigger the production of antinuclear antibodies, a hallmark of SLE.
    • This provides a novel hypothesis for the fundamental cause of drug-induced systemic lupus erythematosus.

    Related Experiment Videos